Eckmann Christian, Aghdassi Seven Johannes Sam, Brinkmann Alexander, Pletz Mathias, Rademacher Jessica
Visceral and Thoracic Surgery and ABS-Team, Clinic Hannoversch Münden; Institute of Hygiene and Environmental Medicine, Charité - University Medicine Berlin , Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program; Department of Anaesthesiology and Intensive Care Medicine, General Hospital of Heidenheim; Institute of Infectious Diseases and Infection Control, University Hospital, Jena,; Department of Pneumolgoy and Infectiology and ABSTeam, Hannover Medical School.
Dtsch Arztebl Int. 2024 Apr 5;121(7):233-242. doi: 10.3238/arztebl.m2024.0037.
Postoperative surgical site infections (SSI) account for almost 25% of all nosocomial infections in Germany and are a source of increased morbidity and mortality.
This review is based on pertinent publications retrieved by a selective search in PubMed and on national and international guidelines.
The individual risk factors for SSI must be assessed before any surgical procedure. A body-mass index above 30 kg/m2 is associated with an unadjusted risk ratio of 1.35 [1.28; 1.41] for SSI, which rises to 3.29 [2.99; 3.62] if the patient is also immunosuppressed. The risk of SSI is also significantly higher with certain types of procedure. Perioperative antibiotic prophylaxis (PAP) is clearly indicated for operations that carry a high risk of SSI (e.g., colorectal surgery) and for those that involve the implantation of alloplastic material (e.g., hip endoprostheses). PAP can usually be administered with basic antibiotics such as cefazoline. The basic principles of PAP are that it should be given by the anesthesia team in the interval from 60 minutes preoperatively up to shortly before the incision, and that its administration should only be for a short period of time, usually as a single shot. Continuing PAP onward into the postoperative period leads to increased toxicity, bacterial superinfections, and antibiotic resistance.
The evidence shows that perioperative antibiotic prophylaxis is a component of a bundle of measures that can help prevent SSI. Strict indications and adherence to the basic principles of PAP are essential for therapeutic success.
术后手术部位感染(SSI)在德国所有医院感染中占近25%,是发病率和死亡率增加的一个来源。
本综述基于通过在PubMed中进行选择性检索以及国家和国际指南检索到的相关出版物。
在任何手术前都必须评估SSI的个体危险因素。体重指数高于30kg/m²与SSI的未调整风险比为1.35[1.28;1.41]相关,如果患者同时免疫抑制,该风险比升至3.29[2.99;3.62]。某些类型的手术中SSI风险也显著更高。围手术期抗生素预防(PAP)对于具有高SSI风险的手术(如结直肠手术)以及涉及植入异体材料的手术(如髋关节假体)明确适用。PAP通常可使用头孢唑林等基础抗生素给药。PAP的基本原则是应由麻醉团队在术前60分钟至切口前不久的时间段内给药,且给药时间应仅为短时间,通常为单次注射。术后继续使用PAP会导致毒性增加、细菌二重感染和抗生素耐药性。
证据表明围手术期抗生素预防是有助于预防SSI的一系列措施的组成部分。严格的适应症和遵守PAP的基本原则对于治疗成功至关重要。